SCHEMBL23935878

SCHEMBL23935878

N=C(NCC1=CC1)NC(=N)N1CCC(F)(F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18191042 0.79 TGM2 (0.38) —
Hydrochloric Acid SCHEMBL18191032 0.75 HRH3 (0.44) —
SCHEMBL23935916 0.75 METAP2 (0.42) —
SCHEMBL23935877 0.75 METAP2 (0.42) —
SCHEMBL18190981 0.75 MTOR (0.39) —
SCHEMBL18197822 0.74 SCN5A (0.43) —
SCHEMBL18191040 0.74 P2RX7 (0.31) —
Hydrochloric Acid SCHEMBL18190999 0.73 SCN5A (0.42) —
Acetic Acid SCHEMBL18190974 0.73 FPR2 (0.40) —
SCHEMBL18197800 0.72 MTOR (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288918-B1 GUANIDINE COMPOUNDS AND USE THEREOF IMMUNOMET THERAPEUTICS INC (US) 2021-10-20 — — EP disclosed
Send feedback